Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dana-Farber Cancer Institute
This research study will test a new clinician decision support tool for the assessment and management of CIPN. The algorithm is designed to help clinicians make decisions about which strategies to use for the assessment and/or management of CIPN. The investigators need to recruit participants receiving chemotherapy that is known to cause CIPN to determine how well the algorithm works to increase clinicians' use of recommended CIPN assessment and management strategies.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
over 18 years of age,
completed one infusion of neurotoxic chemotherapy for the treatment of cancer
has at least three more planned clinic visits associated with neurotoxic chemotherapy receipt after the day of consent
ambulatory,
signed informed consent,
willingness to participate in all study activities,
speaks/reads English,
receives care from one of the clinicians enrolled in the study.
if they are a Medical Doctor, Physician Assistant, or Nurse Practitioner and provide care to oncology patients at one of the study sites
if they are an adult (18+) who does not have cancer or symptoms of peripheral nerve injury from any cause and speak/read English
You may not be if
prognosis of ≤ two months or
documented peripheral neuropathy due to other causes (diabetes, alcohol abuse, central nervous system malignancy, vitamin B deficiency, hereditary, nerve compression injury).
